Private Capital Management (Minnesota)’s Gilead Sciences GILD Stock Holding History

Private Capital Management (Minnesota)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$324K	Sell	4,000 -5,200	-57%	-$398K	0.36%	126
2017 Q2	$651K	Buy	9,200 +150	+2%	+$9.98K	0.72%	43
2017 Q1	$615K	Buy	9,050 +1,250	+16%	+$87.9K	0.67%	48
2016 Q4	$559K	Sell	7,800 -850	-10%	-$63.2K	0.63%	63
2016 Q3	$684K	Hold	8,650	–	–	0.72%	50
2016 Q2	$721K	Buy	8,650 +1,400	+19%	+$124K	0.71%	46
2016 Q1	$666K	Buy	7,250 +1,550	+27%	+$140K	0.61%	58
2015 Q4	$577K	Buy	+5,700	New	+$593K	0.53%	76

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Private Capital Management (Minnesota)'s GILD Position: Q3 2017 in Review

Private Capital Management (Minnesota) reduced its Gilead Sciences (GILD) stake by 57% in Q3 2017, selling an estimated $398K and leaving 4,000 shares worth $324K. The position accounts for 0.36% of the portfolio, ranked #126.

Private Capital Management (Minnesota) first reported a position in GILD in Q4 2015 and has held it in 8 quarters since. The position peaked at $721K in Q2 2016. 1,505 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

Private Capital Management (Minnesota) held 4,000 shares of Gilead Sciences worth $324K as of Q3 2017.
Private Capital Management (Minnesota) sold 5,200 Gilead Sciences shares in Q3 2017, an estimated $398K.
Gilead Sciences made up 0.36% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #126 holding.
Private Capital Management (Minnesota) first reported a position in Gilead Sciences in Q4 2015 and has held it in 8 quarters since.
Private Capital Management (Minnesota)'s Gilead Sciences position peaked at $721K in Q2 2016.
1,505 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.